FDA
- Status: approved
🇺🇸 Flu Vaccine in United States
768 US adverse-event reports
Marketing authorisation
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 768
Most-reported reactions
- Fatigue — 100 reports (13.02%)
- Headache — 90 reports (11.72%)
- Dyspnoea — 85 reports (11.07%)
- Nausea — 81 reports (10.55%)
- Pain — 80 reports (10.42%)
- Diarrhoea — 73 reports (9.51%)
- Arthralgia — 70 reports (9.11%)
- Asthenia — 66 reports (8.59%)
- Malaise — 62 reports (8.07%)
- Pneumonia — 61 reports (7.94%)
Flu Vaccine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Flu Vaccine approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Flu Vaccine in United States?
La Fundacion Favaloro para la Investigacion y la Docencia Medica is the originator. The local marketing authorisation holder may differ — check the official source linked above.